We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

167 hedge funds and large institutions have $1.41B invested in Coherus Oncology in 2019 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 56 increasing their positions, 43 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more call options, than puts

Call options by funds: $15.8M | Put options by funds: $4.99M

115% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 20

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

30% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 43

14% more funds holding

Funds holding: 146 → 167 (+21)

3.11% more ownership

Funds ownership: 96.32% → 99.43% (+3.1%)

5% less capital invested

Capital invested by funds: $1.47B → $1.41B (-$67.9M)

Holders
167
Holders Change
+21
Holders Change %
+14.38%
% of All Funds
3.66%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
43
Increased
56
Reduced
43
Closed
20
Calls
$15.8M
Puts
$4.99M
Net Calls
+$10.8M
Net Calls Change
+$3.31M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$26.7M
2
RHJA
Rice Hall James & Associates
California
+$14.1M
3
N
Nuveen
North Carolina
+$13.3M
4
Ameriprise
Ameriprise
Minnesota
+$9.96M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$9.81M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$15.3M
2
JP Morgan Chase
JP Morgan Chase
New York
-$11.8M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.99M
4
HP
Hound Partners
New York
-$9.47M
5
DCM
Driehaus Capital Management
Illinois
-$9.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRSOTSOK
51
Teachers Retirement System of the State of Kentucky
Kentucky
$3.22M -$601K -30,100 -16%
Jacobs Levy Equity Management
52
Jacobs Levy Equity Management
New Jersey
$3.2M +$410K +20,540 +15%
EAM
53
Erste Asset Management
Austria
$3.17M – – –
CIP
54
Chartwell Investment Partners
Pennsylvania
$3.16M – – –
Rafferty Asset Management
55
Rafferty Asset Management
New York
$3.14M +$1.01M +50,800 +49%
CEP
56
Chicago Equity Partners
Illinois
$2.98M +$2.66M +133,360 +975%
DIA
57
Dana Investment Advisors
Wisconsin
$2.91M +$2.87M +143,727 New
3C
58
361 Capital
Colorado
$2.72M -$61.2K -3,061 -2%
Morgan Stanley
59
Morgan Stanley
New York
$2.7M +$1.51M +75,475 +130%
CCM
60
Cadence Capital Management
Massachusetts
$2.63M +$2.6M +129,992 New
NAM
61
Nexpoint Asset Management
Texas
$2.53M +$2.49M +124,825 New
California Public Employees Retirement System
62
California Public Employees Retirement System
California
$2.32M +$1.92M +96,014 +515%
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$2.07M -$79K -3,956 -4%
Russell Investments Group
64
Russell Investments Group
United Kingdom
$2.03M +$2M +100,004 New
Swiss National Bank
65
Swiss National Bank
Switzerland
$1.98M +$55.9K +2,800 +3%
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$1.95M +$23K +1,152 +1%
State of Wisconsin Investment Board
67
State of Wisconsin Investment Board
Wisconsin
$1.88M +$434K +21,700 +31%
Two Sigma Investments
68
Two Sigma Investments
New York
$1.83M -$1.39M -69,666 -44%
Citigroup
69
Citigroup
New York
$1.77M +$15.4K +771 +0.9%
Barclays
70
Barclays
United Kingdom
$1.77M +$945K +47,315 +119%
AG
71
Algert Global
California
$1.55M +$1.53M +76,508 New
Millennium Management
72
Millennium Management
New York
$1.5M -$2.07M -103,441 -58%
PPA
73
Parametric Portfolio Associates
Washington
$1.48M -$430K -21,517 -23%
FP
74
Foundry Partners
Minnesota
$1.47M +$679K +34,000 +88%
PNC Financial Services Group
75
PNC Financial Services Group
Pennsylvania
$1.41M -$553K -27,668 -28%
1 2
3
4 5

CHRS Hedge Fund Activity: Q3 2019 in Review

167 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q3 2019, worth a combined $1.41B — down 4.6% from $1.47B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new CHRS positions and 20 closed out — a net gain of 23 holders — while 56 added to existing stakes and 43 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $26.7M. The largest seller was PFM Health Sciences, cutting an estimated $15.3M.

  • 167 institutional investors held Coherus Oncology (CHRS) as of Q3 2019, up from 146 in Q2 2019.
  • Funds reported $1.41B of Coherus Oncology stock for Q3 2019, down 4.6% quarter-over-quarter.
  • 43 funds opened new Coherus Oncology positions in Q3 2019 and 20 closed out, a net change of +23 holders.
  • The largest Coherus Oncology buyer in Q3 2019 was Rubric Capital Management (New York), an estimated $26.7M added.
  • The largest Coherus Oncology seller in Q3 2019 was PFM Health Sciences, an estimated $15.3M sold.

Based on aggregated 13F filings for Q3 2019.